Fairport, NYNCT07260877Now EnrollingIRB Ready

Cutaneous Lupus Erythematosus (CLE) Clinical Trial in Fairport, NY

Access cutting-edge cutaneous lupus erythematosus (cle) treatment through this clinical trial at a research site in Fairport. Study-provided care at no cost to qualified participants.

Sponsored by Ventus Therapeutics U.S., Inc.

Quick Self-Assessment

See if you qualify for this Fairport location

Preparing your pre-screening questions…

Expert Care in Fairport

Access cutaneous lupus erythematosus (cle) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related cutaneous lupus erythematosus (cle) treatment provided free

Apply for This Fairport Location

Check if you qualify for this cutaneous lupus erythematosus (cle) clinical trial in Fairport, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Fairport

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Fairport site if eligible
  4. 4Begin participation

About This Cutaneous Lupus Erythematosus (CLE) Study in Fairport

The goal of this clinical trial is to learn if VENT-03 works to treat patients with cutaneous lupus erythematosus (CLE) who may or may not have systemic lupus erythematosus (SLE). Another goal is to learn about the safety of VENT-03 and how it is processed by the body. The main questions it aims to answer are: * Does VENT-03 affect the activity and severity of CLE? * What side effects do participants have when taking VENT-03? Researchers will compare VENT-03 to a placebo (a look-alike substance that contains no drug) to see if VENT-03 works to treat patients with CLE. Participants will: * Take VENT-03 or a placebo for 4 weeks, then all participants will switch to VENT-03 for another 8 weeks; * Visit the clinic once a month for checkups and tests.

Sponsor: Ventus Therapeutics U.S., Inc.

Who Can Participate

Inclusion Criteria

Cutaneous lupus:
CLASI-A score ≥8;
At least 1 active discoid lupus erythematosus (DLE) lesion, OR at least 1 active subacute CLE lesion
If participant has previous SLE diagnosis:
Positive antinuclear antibody test at Screening by immunofluorescent assay at the central laboratory with titer ≥ 1:80;
Meets the American College of Rheumatology/ European Alliance of Associations for Rheumatology 2019 criteria for SLE; and
Currently receiving at least one of the specified SLE medication treatments, at stable doses. Key

Exclusion Criteria

Meet protocol-specified infection or lab criteria; any other laboratory test results that, in the investigator's opinion, might place participant at unacceptable risk for participating in this study;
Moderate or severe liver impairment as classified by the Child-Pugh criteria (categories B and C);
Has drug-induced lupus, rather than 'idiopathic' lupus;
History of, or current, inflammatory joint or skin disease other than SLE and cutaneous lupus;
Diagnosis of select potentially confounding autoimmune disorders
Active severe or unstable neuropsychiatric SLE;
Hospitalization for a severe lupus flare in the past 3 months, or active severe SLE-driven disease, including lupus nephritis, for which in the opinion of the PI the protocol-specified SOC is insufficient;
History of or current diagnosis of anti-phospholipid syndrome;
History of any non-lupus disease that has required treatment with oral or parenteral corticosteroids for more than a total of 2 weeks within the last 24 weeks prior to Day 1;
Meets protocol specified medical history of infectious diseases and infections and/or opportunistic infection requiring hospitalization or parenteral antimicrobial treatment within specified timeframes;
Cancer screening results suspicious of malignancy or history of cancer within time specified with exceptions for curative therapy for squamous or basil cell carcinoma and cervical cancer in situ; and
Meets protocol specified exclusions related to concomitant medications.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Fairport?

Yes, this clinical trial (NCT07260877) has an active research site in Fairport, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Cutaneous Lupus Erythematosus (CLE) Treatment Options in Fairport, NY

If you're searching for cutaneous lupus erythematosus (cle) treatment options in Fairport, NY, this clinical trial (NCT07260877) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Fairport research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cutaneous lupus erythematosus (cle) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all cutaneous lupus erythematosus (cle) clinical trials near you to find additional studies recruiting in your area.

More Lupus Trials in Fairport, NY

See all lupus clinical trials recruiting in Fairport — not just this study.

Browse Lupus Trials in Fairport →

Browse More Trials by Condition

Lupus TrialsAll Conditions →

Ready to Join in Fairport?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Fairport, NY